A citation-based method for searching scientific literature

Jason Charish, Alireza P Shabanzadeh, Danian Chen, Patrick Mehlen, Santhosh Sethuramanujam, Hidekiyo Harada, Vera L Bonilha, Gautam Awatramani, Rod Bremner, Philippe P Monnier. J Clin Invest 2020
Times Cited: 6







List of co-cited articles
69 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


RGMa inhibition with human monoclonal antibodies promotes regeneration, plasticity and repair, and attenuates neuropathic pain after spinal cord injury.
Andrea J Mothe, Nardos G Tassew, Alirezha P Shabanzadeh, Romeo Penheiro, Robin J Vigouroux, Lili Huang, Christine Grinnell, Yi-Fang Cui, Emma Fung, Philippe P Monnier,[...]. Sci Rep 2017
36
50

Different effects of valproic acid on photoreceptor loss in Rd1 and Rd10 retinal degeneration mice.
Kenneth P Mitton, Alvaro E Guzman, Mrinalini Deshpande, David Byrd, Camryn DeLooff, Kristina Mkoyan, Paul Zlojutro, Adrianne Wallace, Brandon Metcalf, Kirsten Laux,[...]. Mol Vis 2014
19
33

Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
Joanna A Korecka, Elizabeth B Moloney, Ruben Eggers, Barbara Hobo, Sanny Scheffer, Nienke Ras-Verloop, R Jeroen Pasterkamp, Dick F Swaab, August B Smit, Ronald E van Kesteren,[...]. J Neurosci 2017
12
33

Diagnostic staging of Parkinson's disease: conceptual aspects.
H Przuntek, Th Müller, P Riederer. J Neural Transm (Vienna) 2004
101
33

Repulsive guidance molecule-a and demyelination: implications for multiple sclerosis.
Takekazu Kubo, Shigeru Tokita, Toshihide Yamashita. J Neuroimmune Pharmacol 2012
10
33

Treating Parkinson's Disease with Antibodies: Previous Studies and Future Directions.
Anne-Marie Castonguay, Claude Gravel, Martin Lévesque. J Parkinsons Dis 2021
3
66

Clinical progression in Parkinson disease and the neurobiology of axons.
Hsiao-Chun Cheng, Christina M Ulane, Robert E Burke. Ann Neurol 2010
454
33


Levodopa increases oxidative stress and repulsive guidance molecule A levels: a pilot study in patients with Parkinson's disease.
Thomas Müller, Isabel Trommer, Siegfried Muhlack, Bernhard K Mueller. J Neural Transm (Vienna) 2016
20
33


Neuroinflammation - a common thread in neurological disorders.
Nils Erik Gilhus, Günther Deuschl. Nat Rev Neurol 2019
37
33

Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease.
Stephen Mullin, Morten Gersel Stokholm, Derralyn Hughes, Atul Mehta, Peter Parbo, Rainer Hinz, Nicola Pavese, David J Brooks, Anthony H V Schapira. Mov Disord 2021
9
33

Repulsive guidance molecules lock growth differentiation factor 5 in an inhibitory complex.
Tomas Malinauskas, Tina V Peer, Benjamin Bishop, Thomas D Mueller, Christian Siebold. Proc Natl Acad Sci U S A 2020
7
33

Alzheimer's disease.
C A Lane, J Hardy, J M Schott. Eur J Neurol 2018
641
33

Parkinson's disease and pesticides: A meta-analysis of disease connection and genetic alterations.
Hussien Ahmed, Abdelrahman Ibrahim Abushouk, Mohamed Gabr, Ahmed Negida, Mohamed M Abdel-Daim. Biomed Pharmacother 2017
44
33

Stem Cell-Based Therapies for Parkinson Disease.
Zhaohui Liu, Hoi-Hung Cheung. Int J Mol Sci 2020
10
33


Human-induced pluripotent stem cells pave the road for a better understanding of motor neuron disease.
Beate Winner, Maria C Marchetto, Jürgen Winkler, Fred H Gage. Hum Mol Genet 2014
16
33

The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017.
Günther Deuschl, Ettore Beghi, Franz Fazekas, Timea Varga, Kalliopi A Christoforidi, Eveline Sipido, Claudio L Bassetti, Theo Vos, Valery L Feigin. Lancet Public Health 2020
46
33

Repulsive Guidance Molecule A Suppresses Adult Neurogenesis.
Toke Jost Isaksen, Yuki Fujita, Toshihide Yamashita. Stem Cell Reports 2020
4
50


The neogenin/DCC homolog UNC-40 promotes BMP signaling via the RGM protein DRAG-1 in C. elegans.
Chenxi Tian, Herong Shi, Shan Xiong, Fenghua Hu, Wen-Cheng Xiong, Jun Liu. Development 2013
23
33

Diagnosis and Treatment of Parkinson Disease: A Review.
Melissa J Armstrong, Michael S Okun. JAMA 2020
279
33

Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.
Anthony E Lang, Steven Gill, Nik K Patel, Andres Lozano, John G Nutt, Richard Penn, David J Brooks, Gary Hotton, Elena Moro, Peter Heywood,[...]. Ann Neurol 2006
678
33

Is Braak staging valid for all types of Parkinson's disease?
Kurt A Jellinger. J Neural Transm (Vienna) 2019
35
33

Neuronal precursor cells with dopaminergic commitment in the rostral migratory stream of the mouse.
Kerstin Schweyer, Corinna Rüschoff-Steiner, Oscar Arias-Carrión, Wolfgang H Oertel, Thomas W Rösler, Günter U Höglinger. Sci Rep 2019
6
33

Multiplicity of α-Synuclein Aggregated Species and Their Possible Roles in Disease.
Pablo Gracia, José D Camino, Laura Volpicelli-Daley, Nunilo Cremades. Int J Mol Sci 2020
7
33

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
Alan L Whone, Ray L Watts, A Jon Stoessl, Margaret Davis, Sven Reske, Claude Nahmias, Anthony E Lang, Olivier Rascol, Maria J Ribeiro, Philippe Remy,[...]. Ann Neurol 2003
597
33

Inhibition of repulsive guidance molecule-a protects dopaminergic neurons in a mouse model of Parkinson's disease.
Wakana Oda, Yuki Fujita, Kousuke Baba, Hideki Mochizuki, Hitoshi Niwa, Toshihide Yamashita. Cell Death Dis 2021
4
50




Cell-based therapy in Alzheimer's disease: Can human fetal cholinergic neurons "untangle the skein"?
Giulia Guarnieri, Erica Sarchielli, Gabriella B Vannelli, Annamaria Morelli. Neural Regen Res 2018
8
33

Decreased levels of repulsive guidance molecule A in association with beneficial effects of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients.
Thomas Müller, Stefan Barghorn, Sven Lütge, Thomas Haas, Reinhold Mueller, Bjoern Gerlach, Gabi Öhm, Katrin Eilert, Isabel Trommer, Bernhard K Mueller. J Neural Transm (Vienna) 2015
9
33

Tau phosphorylation, molecular chaperones, and ubiquitin E3 ligase: clinical relevance in Alzheimer's disease.
Pravir Kumar, Niraj Kumar Jha, Saurabh Kumar Jha, Karunya Ramani, Rashmi K Ambasta. J Alzheimers Dis 2015
32
33

Lewy Bodies: A Spectator or Salient Killer?
Jeswinder Sian-Hulsmann, Camelia Monoranu, S Strobel, Peter Riederer. CNS Neurol Disord Drug Targets 2015
18
33

Mechanisms of neuroplasticity and brain degeneration: strategies for protection during the aging process.
Mariana Toricelli, Arthur Antonio Ruiz Pereira, Guilherme Souza Abrao, Helena Nascimento Malerba, Julia Maia, Hudson Sousa Buck, Tania Araujo Viel. Neural Regen Res 2021
11
33

Biochemical and pharmacological aspects of Parkinsonism.
A Carlsson. Acta Neurol Scand Suppl 1972
53
33

Parkinson's Disease: Biomarkers, Treatment, and Risk Factors.
Fatemeh N Emamzadeh, Andrei Surguchov. Front Neurosci 2018
117
33

Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease.
Carroll Rutherford Fields, Nora Bengoa-Vergniory, Richard Wade-Martins. Front Mol Neurosci 2019
59
33

[The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].
W BIRKMAYER, O HORNYKIEWICZ. Wien Klin Wochenschr 1961
356
33


Penetrance of Glucocerebrosidase (GBA) Mutations in Parkinson's Disease: A Kin Cohort Study.
Roberta Balestrino, Sara Tunesi, Silvana Tesei, Leonardo Lopiano, Anna L Zecchinelli, Stefano Goldwurm. Mov Disord 2020
17
33

Pesticide-induced gene mutations and Parkinson disease risk: a meta-analysis.
Xiaowei Liu, Tao Ma, Bo Qu, Yan Ji, Zhi Liu. Genet Test Mol Biomarkers 2013
13
33


There is no Parkinson disease.
William J Weiner. Arch Neurol 2008
42
33

Ninety-day Local Tolerability and Toxicity Study of ND0612, a Novel Formulation of Levodopa/Carbidopa, Administered by Subcutaneous Continuous Infusion in Minipigs.
Yuval Ramot, Abraham Nyska, Robert R Maronpot, Ronit Shaltiel-Karyo, Yonit Tsarfati, Rosa Anna Manno, Giuseppe Sacco, Oron Yacoby-Zeevi. Toxicol Pathol 2017
17
33

Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?
Glenda Halliday, Heather McCann, Claire Shepherd. Expert Rev Neurother 2012
40
33

Delayed administration of the human anti-RGMa monoclonal antibody elezanumab promotes functional recovery including spontaneous voiding after spinal cord injury in rats.
Andrea J Mothe, Marlon Coelho, Lili Huang, Philippe P Monnier, Yi-Fang Cui, Bernhard K Mueller, Peer B Jacobson, Charles H Tator. Neurobiol Dis 2020
13
33

α-Synuclein induces alterations in adult neurogenesis in Parkinson disease models via p53-mediated repression of Notch1.
Paula Desplats, Brian Spencer, Leslie Crews, Pruthul Pathel, Dinorah Morvinski-Friedmann, Kori Kosberg, Scott Roberts, Christina Patrick, Beate Winner, Juergen Winkler,[...]. J Biol Chem 2012
47
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.